CopilotIQ

CopilotIQ, based in the US, operates as a digital health company providing remote health monitoring solutions specifically designed for seniors managing chronic conditions such as diabetes and hypertension. CopilotIQ is a digital health company that offers innovative telehealth solutions aimed at enhancing the quality of life for older adults. Founded in Nashville, US, the company's headquarters is located there. In October 2024, CopilotIQ merged with Biofourmis in a stock deal, integrating their capabilities in remote patient monitoring.

The company has executed 1 deal, with its most recent deal taking place on October 21, 2024. CopilotIQ specializes in remote health monitoring solutions specifically designed for seniors managing chronic conditions such as diabetes and hypertension. Its core offering is a telehealth platform that combines connected medical devices with personalized support from licensed U. S.

-based nurses. This platform enables high-frequency connected care, allowing users to track vital metrics such as blood glucose and blood pressure in real-time. The data collected through these devices is analyzed to create personalized health plans and provide ongoing support, including regular coaching sessions via phone or video. CopilotIQ serves older adults primarily in 11 states, including Alabama, Florida, Georgia, Indiana, Kentucky, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, and Virginia, aiming to help them improve their health outcomes and reduce medication side effects.

CopilotIQ generates revenue through a subscription model, primarily targeting Medicare and Medicare Advantage plans for reimbursement. The company’s services are positioned as value-added solutions for older adults, with a focus on delivering personalized care that mitigates the need for extensive medical interventions. Clients, which include senior patients and their caregivers, engage with the platform for ongoing health management, often through partnerships with healthcare insurers. The revenue stream is bolstered by recurring fees associated with these subscriptions, ensuring a stable financial foundation as they deliver their flagship remote patient monitoring services and telehealth consultations.

Each client relationship is structured to facilitate direct engagement, enhancing patient accountability and health management effectiveness without delving into specific pricing plans. CopilotIQ aims to expand its product offerings by developing new solutions tailored for chronic condition management, with plans for release throughout 2025. The company is also targeting expansion into new geographic markets, focusing on increasing its presence beyond the current 11 states, specifically looking to enter markets in the Midwest and Northeast regions by mid-2025. The recent merger with Biofourmis will support these initiatives by enhancing technology integration and operational capabilities, although financial terms of the merger were not disclosed.